USPTO serial 79314889
GENETICA
Reviewed by CopyMark Law Group
Status 603
- Filing date
- Status date
- Registration date
- —
- Examiner
- MOSKOWITZ, SAMANTHA
- Law office
- TMO LAW OFFICE 127 - EXAMINING ATTORNEY ASSIGNED
What this means
This page summarizes the public USPTO record for this serial number, including owners, goods and services, and prosecution history.
Need help with GENETICA?
If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.
Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.
Owner
Attorney of record
The USPTO lists this attorney as the applicant's representative for correspondence on this application.
KIMBERLEE A. BOYLE
KIMBERLEE A. BOYLE RICHARD LAW GROUP, INC.13355 NOEL ROAD, SUITE 1350DALLAS, TX 75240UNITED STATESGoods and services
| Class | Description | Status | First use |
|---|---|---|---|
| 010 | Medical apparatus and instruments for use in diagnostic procedures for physical and mental health and wellness; testing apparatus for testing and evaluating saliva samples, DNA and RNA for physical and mental health and wellness; apparatus for DNA and RNA testing for medical purposes; apparatus for use in medical analysis of saliva, DNA and RNA; diagnostic apparatus for diagnosing and risk screening of immunity, nutritional sensitivities, vitamin deficiency, insomnia, metabolism, viruses, diabetes, allergies, autism, ADHD, cancer, stroke, susceptibility to respiratory viral infections, behavior tendencies, and physical and mental fitness and ability; apparatus for the regeneration of stem cells for medical purposes; body composition monitors for medical purposes; saliva collection kits comprised of swabs and tubes for collecting saliva for genetic analysis for medical purposes | ACTIVE | — |
| 042 | Providing medical and scientific research information in the fields of genetics and human genome; technology transfer services, namely, providing technology consultancy in the field of biology and genetics; genetic testing services for scientific research purposes; services of research on sciences relating to genetic biology, hereditary diseases, genes, pharmaceuticals or diagnostic methods derivable from stem cells, stem cell tissues or frames of stem cells, or combinations of the above services; providing information relating to computer, biological and genetic technology; Medical and scientific research, namely, conducting clinical trials for others | ACTIVE | — |
| 044 | Genetic counseling services for medical purposes; health and nutrition counseling services; gene analyzing services for medical purposes; occupational, speech pathology, and mental health therapy services; medical assistance; services of providing information in the field of nutrition and health care | ACTIVE | — |
Related trademarks
CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.
Prosecution history
| Date | Code | Event | What it means |
|---|---|---|---|
| Oct 19, 2024 | FINT | FINAL DECISION TRANSACTION PROCESSED BY IB | — |
| Oct 3, 2024 | FICS | FINAL DISPOSITION NOTICE SENT TO IB | — |
| Oct 3, 2024 | FICR | FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB | — |
| Oct 2, 2023 | MAB3 | ABANDONMENT NOTICE MAILED - AFTER EX PARTE APPEAL | — |
| Oct 2, 2023 | MAB3 | ABANDONMENT NOTICE MAILED - AFTER EX PARTE APPEAL | — |
| Feb 2, 2023 | ABN3 | ABANDONMENT - AFTER EX PARTE APPEAL | — |
| Feb 2, 2023 | EXPT | EXPARTE APPEAL TERMINATED | — |
| Jan 3, 2023 | OPNX | NOTIFICATION OF POSSIBLE OPPOSITION - PROCESSED BY IB | — |
| Dec 19, 2022 | EXFB | EXPARTE APPEAL DISMISSED - FAILURE TO FILE BRIEF | — |
| Dec 14, 2022 | OPNS | NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB | — |
| Dec 14, 2022 | OPNR | NOTIFICATION OF POSSIBLE OPPOSITION CREATED, TO BE SENT TO IB | — |
| Oct 3, 2022 | EXPI | EX PARTE APPEAL-INSTITUTED | — |
| Oct 3, 2022 | EXAF | EXPARTE APPEAL RECEIVED AT TTAB | — |
| Apr 5, 2022 | GNFN | NOTIFICATION OF FINAL REFUSAL EMAILED | — |
| Apr 5, 2022 | GNFR | FINAL REFUSAL E-MAILED | A final Office Action (final refusal) means the examining attorney is maintaining at least one refusal and your options are narrower. You can file a response addressing the refusal, appeal to the Trademark Trial and Appeal Board, or let the application abandon. |
| Apr 5, 2022 | CNFR | FINAL REFUSAL WRITTEN | A final Office Action (final refusal) means the examining attorney is maintaining at least one refusal and your options are narrower. You can file a response addressing the refusal, appeal to the Trademark Trial and Appeal Board, or let the application abandon. |
| Jan 14, 2022 | TEME | TEAS/EMAIL CORRESPONDENCE ENTERED | — |
| Jan 13, 2022 | CRFA | CORRESPONDENCE RECEIVED IN LAW OFFICE | — |
| Jan 13, 2022 | TROA | TEAS RESPONSE TO OFFICE ACTION RECEIVED | This event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action. |
| Aug 22, 2021 | RFNT | REFUSAL PROCESSED BY IB | — |
| Aug 5, 2021 | RFCS | NON-FINAL ACTION MAILED - REFUSAL SENT TO IB | — |
| Aug 5, 2021 | RFRR | REFUSAL PROCESSED BY MPU | — |
| Jul 28, 2021 | RFCR | NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW | — |
| Jul 27, 2021 | CNRT | NON-FINAL ACTION WRITTEN | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Jul 22, 2021 | DOCK | ASSIGNED TO EXAMINER | — |
| Jul 13, 2021 | MAFR | APPLICATION FILING RECEIPT MAILED | — |
| Jul 9, 2021 | NWOS | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED | — |
| Jul 8, 2021 | REPR | SN ASSIGNED FOR SECT 66A APPL FROM IB | — |